As your browser does not support javascript you won't be able to use all the features of the website. We strongly recommend you to enable the javascript in your old browser's settings or download a new one.

Cramer turns bullish on drug stocks with Trump in the White House

As Jim Cramer digested the stunning victory of Donald Trump, he realized the stock market would suddenly become a very different place with different sectors leading the charge.

"The biggest impact of this shocking election is probably on the healthcare group," the "Mad Money" host said.

For over a year, the prospect of Hillary Clinton winning the White House has weighed on drug stocks, especially after she tweeted about cracking down on pharmaceutical price gouging in September of 2015.

But with a Trump regime entering Washington, those worries have pretty much been taken off the table. The Republicans are all about limited regulation and free markets. Thus, Cramer doesn't expect them to crack down on drug pricing...